Canon Inc. (7751) said net income attributable to shareholders rose 12.2% to ¥246.4 billion in the nine months through September, and revised its full-year forecast, now projecting net income of ¥333.0 billion.
Revenue for January-September rose 4.0% to ¥3.43 trillion and operating profit grew 8.4% to ¥327.7 billion, Canon said in its earnings report (kessan tanshin), prepared under U.S. GAAP and released on Oct. 27. Basic earnings per share came to ¥287.24, compared with ¥240.99 a year earlier.
| Item (¥ million) | 9M 2026 | YoY | FY2026 forecast | YoY |
|---|---|---|---|---|
| Revenue | 3,433,357 | +4.0% | 4,766,000 | +3.1% |
| Operating profit | 327,684 | +8.4% | 456,000 | +0.1% |
| Pretax profit | 358,442 | +14.1% | 483,000 | +0.2% |
| Net income attributable to shareholders | 246,409 | +12.2% | 333,000 | +0.3% |
Canon said its full-year forecast had been revised from the previous announcement, and it now projects basic EPS of ¥390.78 for the year. As of Sept. 30, shareholders' equity stood at ¥3.33 trillion, down 4.7% from the end of December, and the equity ratio fell to 52.3% from 56.9%. Treasury shares rose to 500,439,561 from 455,138,571.
The company left its dividend forecast unchanged at ¥160 a share for the year, including an ¥80 interim payout, under a policy of not reducing the dividend and targeting a payout ratio of around 40%.
Separately, the board approved a simplified absorption-type merger with wholly owned subsidiary Canon Electron Tubes & Devices Co., Ltd. (CETD), with Canon as the surviving company. The deal integrates the component businesses the two companies run in the medical business unit, and no shares or cash will be allotted. CETD reported 2025 sales of ¥26.7 billion. Canon expects the impact on consolidated results to be minor.
The merger is scheduled to take effect on Jan. 1, 2027, subject to change by mutual agreement. The quarterly report has not been reviewed by auditors; Canon plans to release a version with the auditor's review report on Oct. 30, 2026.
| Hikari Tsushin, Inc. | |
| Offer price | ¥1,000 per common share |
| M&A / TOB | 1 |
| Guidance | 0 |
| Buybacks | 0 |
| Dividends | 0 |
| Capital | 0 |
| Earnings | 0 |
| People | 0 |
Summaries of public disclosures by Japanese listed companies. Not investment advice; accuracy not guaranteed. Figures and dates in the TDnet originals prevail.
本站內容為日本上市公司公開開示之摘要整理，非投資建議，亦不保證正確。數字與日程以 TDnet 原文為準。
本サイトは日本の上場企業の適時開示を要約したものであり、投資助言ではありません。正確性は保証しません。数値・日程は TDnet の原文が優先します。